Table 1 Patient characteristics
CEP | |||
|---|---|---|---|
Standard (S) | Intensive (I) | P | |
Patient number (%) | 85 (100%) | 79 (100%) | |
Median age (range), in years | 60 (23–70) | 59 (23–70) | 0.46 |
WHO performance status | 0.66 | ||
0 | 24 (28%) | 17 (22%) | |
1 | 48 (56%) | 50 (63%) | |
2 | 13 (16%) | 12 (15%) | |
FIGO stage | 0.43 | ||
IIIA+B | 22 (26%) | 22 (28%) | |
IIIC | 44 (52%) | 42 (53%) | |
IV | 19 (22%) | 15 (19%) | |
Presence of ascites | 31 (36%) | 39 (49%) | 0.15 |
Histologic type | 0.72 | ||
Serous | 59 (69%) | 53 (67%) | |
Endometrioid | 10 (12%) | 6 (8%) | |
Others | 16 (19%) | 20 (25%) | |
Histologic grade | 0.81 | ||
1 | 19 (22%) | 16 (20%) | |
2 | 23 (27%) | 22 (28%) | |
3 | 20 (24%) | 22 (28%) | |
Unknown | 23 (27%) | 19 (24%) | |
Size of residual lesion after surgery | 0.77 | ||
Microscopic | 12 (15%) | 8 (10%) | |
<2 cm | 26 (30%) | 25 (32%) | |
⩾2 cm | 47 (55%) | 46 (58%) | |
